Change in Director / Key Managerial Personnel

Nature of change: Retirement of two senior management personnel and appointment of one new senior management personnel.

Retiring Personnel:

  • Ms. Shanta Gupta, Functional Head Human Resources & Administration and member of the Senior Management Team, will retire effective close of business hours on June 30, 2026.
  • Dr. Nitin Dharmadhikari, Chief Operating Officer and member of the Senior Management Team, will retire effective close of business hours on June 30, 2026.

Appointed Personnel:

  • Mr. Prasanna Deshmukh has been appointed as Functional Head Human Resources & Administration and will be designated as Senior Management Personnel effective July 01, 2026.

Brief profile and relevant qualifications or experience for Mr. Prasanna Deshmukh:

  • Mr. Prasanna Deshmukh received his Master's in HRM & LR from Tata Institute of Social Sciences, Mumbai.
  • Before joining SPARC, he was associated with Sun Pharmaceutical Industries Ltd. (SPIL) as HR Business Partner - Global Quality and Compliance.
  • In this role, he partnered with the GQC BU across sites worldwide, driving people strategy aligned with rigorous regulatory and compliance standards.
  • He has been with SPIL since May 2023.
  • Prior to SPIL, he was associated with Marico Ltd. and Crompton Ltd.

Disclosure of Relationship between Directors: Not Applicable, as the changes are for senior management personnel, not directors.

Confirmation of eligibility: The disclosure is made in compliance with Regulation 30 read with Schedule III of the SEBI Listing Regulations and includes additional details as required by SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Key Financial or Operational Approvals

This section is not applicable as the disclosure solely concerns changes in senior management personnel and does not contain information on financial results, fundraising, acquisitions, or capital expenditures.

Strategic or Business Context

This section is not applicable as the disclosure does not contain any commentary on business outlook, risks, trends, or strategic developments.

Any Other Material Information

The disclosure is signed by Kajal Damania, Company Secretary and Compliance Officer for Sun Pharma Advanced Research Company Limited.

The intimation was filed with the National Stock Exchange of India Ltd. and BSE Limited on June 26, 2026.